13F-HR filed by QVT Financial LP
QVT Financial LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 35 holding rows worth $1,122,074,939.
- Accession
- 0000950123-25-002585
- Filer
- CIK 1290162
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 35 entries on the cover page, a total value of $1,122,074,939 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,122,074,939 with VALUE read as dollars as filed, 13F file number 028-11172. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ROIVANT SCIENCES LTD | G76279101 | SHS | 65,793,779 | $778,340,406 | dollars as filed | |
| Goldman Sachs Group,Inc. | 38141G104 | COM | 67,926 | $38,895,786 | dollars as filed | |
| OKEANIS ECO TANKERS COR SHS | Y64177101 | Stock | 1,423,997 | $27,246,759 | dollars as filed | |
| NELNET INC | 64031N108 | CL A | 229,665 | $24,530,519 | dollars as filed | |
| MP MATERIALS CORP | 553368101 | COM CL A | 1,531,571 | $23,892,508 | dollars as filed | |
| Berkshire Hathaway Inc | 084670702 | COM | 47,946 | $21,732,963 | dollars as filed | |
| NEXSTAR MEDIA GROUP INC COMMON STOCK | 65336K103 | Stock | 121,587 | $19,207,098 | dollars as filed | |
| ALLOT LTD | M0854Q105 | SHS | 3,205,793 | $19,074,468 | dollars as filed | |
| MAKEMYTRIP LIMITED MAURITIUS | 56087FAB0 | NOTE 2/1 | 6,500,000 | $18,935,191 | dollars as filed | principal |
| NEW YORK TIMES CO MTN BE CL A | 650111107 | Stock | 316,947 | $16,497,091 | dollars as filed | |
| ANTERIX INC | 03676C100 | COMMON STOCK | 503,941 | $15,455,870 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 711,275 | $14,424,657 | dollars as filed | |
| SEA LTD | 81141RAG5 | NOTE 0.250% 9/1 | 15,000,000 | $13,654,636 | dollars as filed | principal |
| LIBERTY LATIN AMERICA LTD | G9001E128 | COM CL C | 1,749,467 | $11,091,621 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 16,498 | $10,146,270 | dollars as filed | |
| NIO INC | 62914VAF3 | NOTE 0.500% 2/0 | 8,500,000 | $8,442,932 | dollars as filed | principal |
| ZIM INTEGRATED SHIPPING SERV | M9T951109 | SHS | 346,500 | $7,439,355 | dollars as filed | put |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 2,313,702 | $7,299,730 | dollars as filed | |
| NOBLE CORP PLC ORD SHS A | G65431127 | Stock | 208,634 | $6,551,108 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 360,524 | $6,433,551 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 170,006 | $6,349,724 | dollars as filed | |
| INFINERA CORP | 45667GAE3 | BOND | 5,000,000 | $5,485,330 | dollars as filed | principal |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 678,564 | $5,021,374 | dollars as filed | |
| WARNER BROS DISCOVERY INC COM SER A | 934423104 | Stock | 457,850 | $4,839,474 | dollars as filed | |
| COMTECH TELECOMMUNICATIONS C | 205826209 | COM NEW | 605,773 | $2,429,150 | dollars as filed | |
| INFORMATICA INC | 45674M101 | COM CL A | 90,817 | $2,354,885 | dollars as filed | |
| SYNOPSYS INC COM | 871607107 | Stock | 3,886 | $1,886,109 | dollars as filed | |
| JD.COM INC SPON ADS CL A | 47215P106 | ADR | 32,274 | $1,118,940 | dollars as filed | |
| GRAY MEDIA INC | 389375106 | COMMON STOCK | 291,452 | $918,074 | dollars as filed | |
| INFINERA CORP | 45667GAG8 | BOND | 718,000 | $851,653 | dollars as filed | principal |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 4,813 | $408,094 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 3,117 | $378,996 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 19,613 | $359,899 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 4,429 | $291,118 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 62,657 | $89,600 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-25-002585 | this filing | 2025-02-14 | acceptance time not in the bulk data set |